S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › ERD › Research report
← ERD page
XStocksXray
Market X-Ray report · 20 October 2026

Eroad Ltd (ERD)

Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026

Key indicators

Last closeAUD 0.800
52-week range0.650 – 1.960
Return, 1 month / 3 months−4.8% / −2.4%
Return, 1 year / 3 years−50.9% / +32.2%
TrendBelow its 200-day average
RSI (14)50
Volatility (1 year)52.4%
Worst drawdown (1 year)-65.2%
Average daily value traded0.04M AUD
Dividend yield–

Market X-Ray price-based

51/ 100 · High confidence · ahead of 51% of stocks on this exchange
Trend53
Momentum51
Stability (higher is calmer)50
Liquidity51
Income–

Five-year price chart navy: price · brown: 200-day average

0.171.272.383.494.602021-102023-012024-042025-072026-10

About the company

EROAD builds and supplies electronic systems for road-user charging and fleet management, mainly for operators of heavy vehicles such as trucks and commercial fleets. Its equipment records distance travelled and reports it so customers can pay road user charges electronically, and the same platform provides telematics data on vehicle location, driver behaviour and compliance. The company is based in New Zealand and serves transport operators in its home market and overseas.

On this site Eroad Ltd appears as a stock on the Australian Securities Exchange (Australia), code ERD, with prices in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Eroad Ltd (ERD) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.800 on 20 October 2026.

Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 889 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 50.9% and over the last three months it fell 2.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Eroad Ltd (ERD)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend53 · FairMixed trend against its averages.
Above 200-day average-3.5%
From 52-week high-57.4%
Momentum51 · FairTypical recent returns for this exchange.
3-month return-2.4%
6-month return3.9%
12-month return, skipping the last month-48.5%
Stability (higher is calmer)50 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)52.4%
Worst drawdown, 1 year (smaller is calmer)-65.2%
Liquidity51 · FairModerate trading activity.
Average daily value traded0.04M AUD
Zero-volume days6.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−0.6%
1 month−4.8%
3 months−2.4%
6 months+3.9%
1 year−50.9%
3 years+32.2%
5 years−81.3%

Signals

50-day / 200-day average0.803 / 0.829
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.032

Technical summary

DailyNeutral5 bullish · 4 neutral · 7 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026